Skip to main content
placeholder image

Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors.

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2015

Citation


  • Lickliter, J. D., Panizza, B., Karapetis, C. S., Gordon, V. A., Reddell, P. W., Lingard, K. T., . . . De Souza, P. (2015). Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors.. Journal of Clinical Oncology, 33(15_suppl), tps2616. doi:10.1200/jco.2015.33.15_suppl.tps2616

Web Of Science Accession Number


Start Page


  • tps2616

End Page


  • tps2616

Volume


  • 33

Issue


  • 15_suppl

Place Of Publication


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2015

Citation


  • Lickliter, J. D., Panizza, B., Karapetis, C. S., Gordon, V. A., Reddell, P. W., Lingard, K. T., . . . De Souza, P. (2015). Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors.. Journal of Clinical Oncology, 33(15_suppl), tps2616. doi:10.1200/jco.2015.33.15_suppl.tps2616

Web Of Science Accession Number


Start Page


  • tps2616

End Page


  • tps2616

Volume


  • 33

Issue


  • 15_suppl

Place Of Publication